{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:23:45Z","timestamp":1785846225116,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Carl Gustav Carus Dresden an der Technischen Universit\u00e4t Dresden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To report contemporary epidemiological data and treatment trends for upper tract urothelial carcinoma (UTUC) in Germany over a 14-year period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed data from the nationwide German hospital billing database and the German cancer registry from 2006 to 2018\/2019. The significance of changes over time was evaluated via regression analysis. Survival outcomes were calculated using the Kaplan\u2013Meier method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was a non-significant increase in the age-standardized incidence rate from 2.5\/100,000 in 2006 to 2.9\/100.000 in 2018. 13% of patients presented with lymph node metastasis and 7.6% of patients presented with distant metastasis at primary diagnosis. The 5-year overall survival was estimated at 45% and the 10-year overall survival at 32%. Endoscopic biopsies of the renal pelvis and ureter as well as ureteroscopies with excision\/destruction of UTUC all increased significantly over the study period. The number of radical nephroureterectomies (RNU) for UTUC steadily increased from 1643 cases in 2006 to 2238 cases in 2019 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005) with a shift from open surgery towards minimally invasive surgery. Complex reconstructive procedures like ileal ureter replacement or autotransplantation are rarely performed for urothelial carcinoma of the ureter.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Diagnostic and therapeutic procedures for UTUC have increased and minimally invasive nephroureterectomy is the predominant approach concerning radical surgery in 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-022-04219-5","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T14:03:46Z","timestamp":1669730626000},"page":"127-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9634-2632","authenticated-orcid":false,"given":"Roman","family":"Herout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Baunacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Flegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Borkowetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Reicherz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kraywinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Groeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"4219_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71:7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"4219_CR2","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s00345-020-03576-3","volume":"39","author":"B Alm\u00e5s","year":"2021","unstructured":"Alm\u00e5s B, Halvorsen OJ, Johannesen TB, Beisland C (2021) Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World J Urol 39:3385\u20133391. https:\/\/doi.org\/10.1007\/s00345-020-03576-3","journal-title":"World J Urol"},{"key":"4219_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2021","unstructured":"Roupr\u00eat M, Babjuk M, Burger M et al (2021) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 79:62\u201379. https:\/\/doi.org\/10.1016\/j.eururo.2020.05.042","journal-title":"Eur Urol"},{"key":"4219_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cncr.11446","volume":"98","author":"S Daneshmand","year":"2003","unstructured":"Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer 98:55\u201360. https:\/\/doi.org\/10.1002\/cncr.11446","journal-title":"Cancer"},{"key":"4219_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.urology.2005.12.034","volume":"67","author":"M Roupr\u00eat","year":"2006","unstructured":"Roupr\u00eat M, Hupertan V, Traxer O et al (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67:1181\u20131187. https:\/\/doi.org\/10.1016\/j.urology.2005.12.034","journal-title":"Urology"},{"key":"4219_CR6","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.ejso.2014.06.007","volume":"40","author":"R Yakoubi","year":"2014","unstructured":"Yakoubi R, Colin P, Seisen T et al (2014) Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. Eur J Surg Oncol 40:1629\u20131634. https:\/\/doi.org\/10.1016\/j.ejso.2014.06.007","journal-title":"Eur J Surg Oncol"},{"key":"4219_CR7","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1016\/j.ejca.2009.06.016","volume":"45","author":"G Lughezzani","year":"2009","unstructured":"Lughezzani G, Jeldres C, Isbarn H et al (2009) Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients. Eur J Cancer 45:3291\u20133297. https:\/\/doi.org\/10.1016\/j.ejca.2009.06.016","journal-title":"Eur J Cancer"},{"key":"4219_CR8","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.3892\/ol.2018.9463","volume":"16","author":"T Kato","year":"2018","unstructured":"Kato T, Nakayama R, Haba T et al (2018) Oncological and renal outcomes of segmental ureterectomy vs. radical nephroureterectomy for upper tract urothelial carcinoma. Oncol Lett 16:6861\u20136867. https:\/\/doi.org\/10.3892\/ol.2018.9463","journal-title":"Oncol Lett"},{"key":"4219_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.5489\/cuaj.2255","volume":"8","author":"JS Banerji","year":"2014","unstructured":"Banerji JS, George AJP (2014) Total ureterectomy and ileal ureteric replacement for TCC ureter in a solitary kidney. Can Urol Assoc J 8:938. https:\/\/doi.org\/10.5489\/cuaj.2255","journal-title":"Can Urol Assoc J"},{"key":"4219_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12894-018-0389-5","volume":"18","author":"Y-C Ou","year":"2018","unstructured":"Ou Y-C, Hu C-Y, Cheng H-L, Yang W-H (2018) Long-term outcomes of total ureterectomy with ileal-ureteral substitution treatment for ureteral cancer: a single-center experience. BMC Urol 18:73. https:\/\/doi.org\/10.1186\/s12894-018-0389-5","journal-title":"BMC Urol"},{"key":"4219_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12957-018-1338-1","volume":"16","author":"MWW Janssen","year":"2018","unstructured":"Janssen MWW, Linxweiler J, Philipps I et al (2018) Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery. World J Surg Oncol 16:35. https:\/\/doi.org\/10.1186\/s12957-018-1338-1","journal-title":"World J Surg Oncol"},{"key":"4219_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/pcan.2016.34","volume":"19","author":"C Groeben","year":"2016","unstructured":"Groeben C, Koch R, Baunacke M et al (2016) Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013. Prostate Cancer Prostatic Dis 19:412\u2013416. https:\/\/doi.org\/10.1038\/pcan.2016.34","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4219_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A et al (2015) The reporting of studies conducted using observational routinely-collected health Data (RECORD) Statement. PLOS Med 12:e1001885. https:\/\/doi.org\/10.1371\/journal.pmed.1001885","journal-title":"PLOS Med"},{"key":"4219_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.euo.2020.11.005","volume":"4","author":"C Coll\u00e0 Ruvolo","year":"2021","unstructured":"Coll\u00e0 Ruvolo C, Nocera L, Stolzenbach LF et al (2021) Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma. Eur Urol Oncol 4:792\u2013801. https:\/\/doi.org\/10.1016\/j.euo.2020.11.005","journal-title":"Eur Urol Oncol"},{"key":"4219_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2011) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005. BJU Int 107:1059\u20131064. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09675.x","journal-title":"BJU Int"},{"key":"4219_CR16","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1111\/bju.12025","volume":"112","author":"MF Eylert","year":"2013","unstructured":"Eylert MF, Hounsome L, Verne J et al (2013) Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985\u20132010. BJU Int 112:E107-113. https:\/\/doi.org\/10.1111\/bju.12025","journal-title":"BJU Int"},{"key":"4219_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/bju.13232","volume":"117","author":"R Woodford","year":"2016","unstructured":"Woodford R, Ranasinghe W, Aw H et al (2016) Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria - Australia. BJU Int 117:45\u201349","journal-title":"BJU Int"},{"key":"4219_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12957-021-02236-z","volume":"19","author":"R Piszczek","year":"2021","unstructured":"Piszczek R, Nowak \u0141, Krajewski W et al (2021) Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis. World J Surg Oncol 19:129. https:\/\/doi.org\/10.1186\/s12957-021-02236-z","journal-title":"World J Surg Oncol"},{"key":"4219_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.euf.2017.10.003","volume":"5","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Seisen T, Dominguez-Escrig J-L et al (2019) Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an european association of urology guidelines systematic review. Eur Urol Focus 5:205\u2013223. https:\/\/doi.org\/10.1016\/j.euf.2017.10.003","journal-title":"Eur Urol Focus"},{"key":"4219_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.eururo.2009.06.013","volume":"56","author":"G Simone","year":"2009","unstructured":"Simone G, Papalia R, Guaglianone S et al (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56:520\u2013526. https:\/\/doi.org\/10.1016\/j.eururo.2009.06.013","journal-title":"Eur Urol"},{"key":"4219_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O\u2019Brien","year":"2011","unstructured":"O\u2019Brien T, Ray E, Singh R et al (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60:703\u2013710. https:\/\/doi.org\/10.1016\/j.eururo.2011.05.064","journal-title":"Eur Urol"},{"key":"4219_CR22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","volume":"31","author":"A Ito","year":"2013","unstructured":"Ito A, Shintaku I, Satoh M et al (2013) Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol 31:1422\u20131427. https:\/\/doi.org\/10.1200\/JCO.2012.45.2128","journal-title":"J Clin Oncol"},{"key":"4219_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, Babjuk M, Comp\u00e9rat E et al (2018) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73:111\u2013122. https:\/\/doi.org\/10.1016\/j.eururo.2017.07.036","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-022-04219-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T13:07:34Z","timestamp":1674047254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-022-04219-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["4219"],"URL":"https:\/\/doi.org\/10.1007\/s00345-022-04219-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}